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Effects of sulfhydryl modification on the ATP regulated K’ channel (K,,, channel) in the pancreatic B-cell were studied, using the patch clamp 
technique. Application of the sulfhydryl oxidizing agents thimerosal and 
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2. MATERIALS AND METHODS 
Thimerosal (mercury-[(o-carboxyphenyl)thio]-ethyl sodium), 
DTBNP and dithiothreitol (DTT) were from Sigma. All other chemi- 
cals were of analytical grade and were either from Sigma or Merck. 
DTBNP was dissolved in dimethyl sulfoxide (DMSO), the final con- 
centration of DMSO being not more than 0.1%. 
2.1. Preparation of cells 
Pancreatic islets from adult obese mice (ob/ob) were isolated by 
collagenase digestion and dispersed into single cells by shaking in a 
Ca”- and Mg”-deficient medium, as previously described [3]. Cells 
were plated on petri dishes and cultured for l-3 days in RPM1 1640 
medium, containing 11 mM glucose and supplemented with fetal calf 
serum (10% v/v), penicillin (100 IUlml) and streptomycin (lOO&ml). 
2.2. Electrophysiology 
We used inside-out, outside-out and whole-cell modes of the patch- 
clamp technique [25]. Pipettes were pulled from borosilicate glass and 
coated with Sylgard resin (Dow Coming) near the tips, fire-polished 
and had resistances between 2 and 6 MR. Single-channel currents were 
recorded from inside-out or outside-out membrane patches and chan- 
nel activity was measured at 0 mV membrane potential. The mem- 
brane potential was monitored using the whole-cell technique. Current 
and voltage were recorded using an Axopatch 200 patch-clamp ampli- 
fier (Axon Instruments Inc. Foster City, USA). During experiments 
the current and voltage signals were stored using a VR-100A digital 
recorder (Instrutech Corp., USA) and a high-resolution video cassette 
recorder (JVC, Japan). Channel records are displayed according to the 
convention with upward deflections denoting outward currents. K,,, 
channel activity was identified on the basis of the sensitivity to ATP 
and the unitary amplitude (1.552 PA). 
In all experiments the extracellular solution contained (in mM): 138 
NaCI, 5.6 KCl, 1.2 MgCl,, 2.6 CaCl,, and 5 HEPES (pH 7.4 with 
NaOH). The ‘intracellular-like’ solution consisted of (in mM): 125 
KCI, 1 MgCl,, 10 EGTA, 30 KOH, and 5 HEPES (pH 7.15 with 
KOH). Patches were excised into nucleotide-free solution and ATP 
was first added to test for channel inhibition. ATP was then removed 
and patches were subsequently exposed to the test substances, as 
indicated in the figures. Mg-ATP (0.1 mM) was present in the intracel- 
lular solution for most of the time to reduce run-down of the K,,, 
channel [26]. The bath had a volume of 0.4 ml and cells were perifused 
at a rate of 4 ml/min. All test compounds were added to the perifusion 
medium. Each experimental condition was tested, with identical re- 
sults, in 3-6 different patches. All experiments were done at room 
temperature (22°C). 
The current signal was filtered at 100 Hz (-3 dB value) by using an 
8-pole Bessel filter (Frequency Devices, Haverhill, USA). Single-chan- 
nel conductance was measured directly from a digital oscilloscope. 
Figures were made by plotting segments of the records on a chart 
10 pMThlm 
recorder, scanning the segments using a HP scanner and incorporatmg 
them into Core1 Draw graphics software program. 
3. RESULTS 
The inhibitory action of thimerosal on KATP channel 
activity was rapid and almost complete with 10 ,uM of 
the compound (Fig. 1). The blocking effect was dose- 
dependent, with a threshold concentration of thimer- 
osal of about l-2 PM. At higher concentrations (up to 
100 PM), thimerosal invariably caused complete inhibi- 
tion of channel activity (data not shown). Replacement 
of the thimerosal-containing solution with thimerosal- 
free solution did not cause spontaneous return of chan- 
nel activity, even when observed for a prolonged period 
of time (up to 5 min). However, addition of 2 mM DTT, 
a disulfide reducing agent [27] readily reversed the in- 
hibitory action of thimerosal and caused a substantial 
return of channel activity. Similar reversal of the inhib- 
itory action of thimerosal was obtained by the disulfide 
reducing agent cysteine (100 PM) (data not shown). 
Although these reducing agents readily reversed the in- 
hibitory effect of thimerosal, they themselves, did not 
have any effect on channel activity (Fig. 2A). DTT did 
not block the inhibitory effect of ATP on the K,,, 
channel (Fig. 2B). We did not observe any effect of 
thimerosal (lo-20pM) on the Ca”-sensitive K’ channel 
(BK channel). 
Fig. 3 shows the inhibitory effect of a representative 
reactive disulfide, DTBNP on the K,,, channel. On 
addition of DTBNP (20 PM), there was a rapid and 
pronounced reduction in channel activity. In control 
experiments, 0.1% DMSO (solvent for DTBNP) had no 
effect on channel activity. The inhibitory effect of 
DTBNP was also partially reversed by the reducing 
agents DTT (Fig. 3) and cysteine (data not shown). 
Since thimerosal is hydrophilic and therefore poorly 
membrane permeable, it is likely that was affecting SH 
groups on the cytoplasmic side of the cell membrane. 
This was confirmed in experiments using the outside- 
out patch configuration, where the extracellular face of 
0.1 mM ATP 1mMDTT 
3 PA 1 
Fig. 1. Effects of thimerosal and DTT on KATp channel activity. Single-channel recordings from excised inside-out membrane patches obtained 
from cultured mouse B-cells. The pipette contained extracellular solution and the cell was perifused with intracellular-like solution. Thimerosal (10 
PM) almost completely blocked the current through the K,,, channel. The blocking effect of thimerosal was not spontaneously reversed upon 
withdrawal of the substance. Addition of D’lT (2 mM) to the same patch, reversed the inhibitory effect of thimerosal. 
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Fig. 2. Single-channel recordings from excised inside-out membrane patches. The the conditions of experiments were as described in the legend 
to Fig. 1. (A) DTT did not affect KATP channel activity in the absence of ATP. (B) DTT had no effect on ATP-induced (0.1 mM) inhibition of 
K,,, channel. 
the cell membrane is exposed to the perifusion medium. 
Addition of a high concentration of thimerosal (100 
PM), no longer blocked the activity of the KATp channel 
(Fig. 4A). On the contrary, application of DTBNP, 
which is highly lipophilic, under the same conditions 
caused rapid inhibition of the channel (Fig. 4B). 
Membrane potentials were recorded from the /?-cell 
in the whole-cell patch clamp configuration, with the 
pipette containing ATP-free intracellular-like solution. 
The decrease in intracellular ATP caused opening of the 
K ATP channel and membrane repolarization. Thimer- 
osal (up to 100 PM), applied to the extracellular face of 
the plasma membrane did not depolarize the cell, 
whereas ubsequent application of DTBNP (50 PM) did 
(Fig. 5). Application of DTBNP (50 PM) alone. without 
prior addition of thimerosal, had a similar effect on 
membrane potential (data not shown). 
4. DISCUSSION 
We demonstrate effects of sulfhydryl oxidation, by 
thimerosal and DTBNP, on K,,, channel activity in the 
pancreatic/?-cell. Thimerosal inibited channel activity in 
a dose-dependent manner and was effective in low mi- 
cromolar concentrations, with maximal inhibitory ef- 
fect obtained at 1 O-20 PM. Thus, thimerosal was a more 
potent inhibitor of this channel than for example tolbu- 
tamide, an example of the first generation of antidia- 
betic sulfonylureas [6]. The effect of thimerosal was re- 
versed by addition of excess of the disulfide reducing 
agent DTT or cysteine. This indicates that inhibition of 
channel activity was caused by sulthydryl oxidation and 
not due to a nonspecific effect on the channel. However, 
the biochemical reaction of thimerosal is not known to 
be specific for any particular type of SH group. Such 
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Fig. 3. Effect of DTBNP on K,,, channel activity in a single-channel recording from an excised inside-out patch. The pipette contained extracellular 
solution and the bath was perfused with mtracellular-like solution. Addition of DTBNP (20 PM) almost totally blocked channel activity. The 
blocking effect was not reversed following wash out of DTBNP. Upon addition of DTT (2 mM), KATP channel activity was partrally restored 
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Fig. 4. Single channel recordings from excised outside-out membrane patches. The pipette was filled with intracellular-like solution and the patch 
was perfused with extracellular medium. (A) Thimerosal (100 PM) did not affect K ATP currents when applied to the extracellular face of the 
membrane. (B) Application of 50 PM DTBNP completely blocked KATP channel activity in the outside-out membrane patch. 
mercurial compounds may also bind to functional 
groups other than SH groups [28]. For this reason, we 
tested the effect of another sulfhydryl oxidizing agent, 
DTBNP. This substance belongs to a class of com- 
pounds known as ‘reactive disulfides’ [29]. DTBNP and 
related dithiopyridines are almost absolutely specific for 
free SH groups, which they oxidize through a thiol- 
disulfide exchange reaction [29,30]. Like thimerosal, 
DTBNP was also a potent inhibitor of the K,,, chan- 
nel. In contrast to the effect of thimerosal, inhibition of 
K ATP channel activity by DTBNP was not reversed to 
the same extent by the reducing agents. This is not 
surprising, since it is known that the reaction of 
DTBNP with SH groups can be irreversible [31]. 
At the concentrations used in this study, thimerosal 
was effective only when applied to the cytoplasmic face 
of the membrane. There was no inhibition of K,, chan- 
nel activity and no depolarization of the membrane, 
when thimerosal was applied to the extracellular side of 
the membrane. This suggests that the site of the critical 
SH groups, associated with the K,,, channel, is on the 
cytoplasmic side of the plasma membrane. Thimerosal, 
being hydrophilic and poorly membrane permeable, 
cannot access these SH groups when applied to the 
extracellular side of the membrane. In contrast to thim- 
erosal, DTBNP is lipophilic and membrane permeable. 
As expected, application of DTBNP to the extracellular 
face of the membrane also caused inhibition of the K,, 
channel and consequently, membrane depolarization. 
Since the effect of thimerosal was observed in the ex- 
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Fig. 5. Whole-cell recordings from B-cells showing effects of thimerosal and DTBNP on membrane potential. Cells were intracellularly perfused 
with an ATP-free intracellular-like solution and the bath was perfused with extracellular solution. Prior to the experiments, cells were cultured in 
media containing 11 mM glucose and because of the short time before the start of an experiment, he cells occasionally exhibited action potentials. 
As the pipette solution lacked ATP, the cells quickly repolarized to about -70 mV. Thimerosal, in concentrations up to 100 PM, did not affect 
membrane potential, whereas DTBNP (50 PM) readily induced membrane depolarization. Vertical bars in the trace. indicate a brake in the record 
of approximately 3 min. 
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cised inside-out patch configuration, it is likely to repre- 
sent a direct interaction with the KATP channel or a 
closely associated protein. 
These results establish the presence of accessible free 
SH groups on the K,,, channel in the pancreatic j&cell, 
as has been suggested for the KATp channel in mouse 
skeletal muscle [20]. Our results indicate that the SH 
groups are critically important for the regulation of 
K ATP channel activity. There are many reports of alter- 
ations in the function of different ion channels caused 
by modification of sulfhydryl or disulfide groups on the 
channel protein. Such effects have been described, for 
instance, on the nicotinic acetylcholine receptor and on 
intracellular Ca” channels such as the ryanodine and 
the inositol 1,4,5-trisphosphate (Ins( 1,4,5)P,) receptor 
[17-19,30,32]. Noteworthy is, that sulfhydryl oxidation 
leads to opening of the intracellular Ca*+ channels, 
whereas in the case of the KArp channel the result of a 
similar chemical modification is the opposite [19,30]. 
Closure of the KATP channel may be the underlying 
mechanism by which some sulfhydryl reagents, that ox- 
idize relatively superficial SH groups, also strongly 
stimulate insulin secretion [21-241. The mechanism of 
insulin secretion by the antidiabetic sulfonylureas also 
involves selective inhibition of the KATP channel. How- 
ever, the molecular basis of the interaction of the sulfon- 
ylureas with the KArr channel or any associated pro- 
teins is still unknown, although it has been suggested 
that their mechanism of action may involve an interac- 
tion with membrane-associated SH groups [33-351. The 
present study also suggests that sulfhydryl modification 
may be a means for developing selective insulinotropic 
agents, as has been done for the development of some 
other classes of drugs [36,37]. Whether thiol-dependent 
redox mechanisms may play a role, also in the physio- 
logical regulation of the stimulus-secretion coupling in 
the pancreatic p-cell, as has been suggested before [38], 
is not clear. In principle, however, it is possible that the 
activity of the KArr channel may be modulated by me- 
tabolism-induced changes in the redox state in the close 
vicinity of the channel. Such switching mechanisms, by 
thiol-dependent redox regulation, have been postulated 
for other biological processes [39-41]. 
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